Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_2628AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineGES-11.0E+4 cells per wellNAMTT assay100 MOI5% cell growth suppression after day 3NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2629AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineGES-11.0E+4 cells per wellNAMTT assay100 MOI15% cell growth suppression after day 4NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2630AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineSGC-7901NANANANANABALB/c nude mice xenograft for SGC7901 (1.0E+6 cells)1.0E+9 pfuNA Complete regression in tumor after 9 weeks and increase in median survival time upto 55 daysIntratumoralInduction of apoptosis in cancerNANA22842823
OV_2631AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineSGC-7901NANANANANABALB/c nude mice xenograft for SGC7901 (1.0E+6 cells)1.0E+9 pfuNA Significant reduction in tumor volume and increase in median survival time ipto 345 daysIntravenousInduction of apoptosis in cancerNANA22842823
OV_2632AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseYesNoNoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI80% cell survival after 3 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2633AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseYesNoNoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI60% cell survival after 6 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2634AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseYesNoNoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOI90% cell survival after 3 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2635AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseYesNoNoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOI60% cell survival after 6 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2636AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI70% cell survival after 3 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2637AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI30% cell survival after 6 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2638AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI60% cell survival after 3 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2639AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI20% cell survival after 6 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2640AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOI60% cell survival after 3 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2641AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOI30% cell survival after 6 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2642AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOI60% cell survival after 3 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2643AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOI20% cell survival after 6 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2644AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay0.001 MOI80% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2645AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay0.01 MOI80% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2646AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay0.1 MOI60% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2647AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI50% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2648AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay10 MOI40% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2649AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay0.001 MOI80% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2650AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay0.01 MOI70% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2651AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay0.1 MOI40% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2652AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI20% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2653AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay10 MOI10% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2654AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay0.001 MOI80% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2655AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay0.01 MOI80% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2656AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay0.1 MOI60% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2657AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOI50% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2658AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay10 MOI30% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2659AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay0.001 MOI70% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2660AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay0.01 MOI70% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2661AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay0.1 MOI30% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2662AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOI20% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2663AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay10 MOI10% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2664AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-231NANANANANABALB/c nude mice xenograft for MDA-MB-231(5.0E+6 cells)1.0E+9 pfuNA Increase in median survival time to more than 100 days compared to control and reduction in tumor volume 663.85 +/- 379.39mm compared to control 1336.46 +/- 614.81NACombination of drug and virus increase the apoptosis processNANA23000515
OV_2690AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNASpectrophotometer10 MOI85% cell viability after 24 hoursNoNoNA No responseNANANANA23028626
OV_2691AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNASpectrophotometer10 MOI80% cell viability after 48 hoursNoNoNA No responseNANANANA23028626
OV_2692AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNASpectrophotometer10 MOI60% cell viability after 72 hoursNoNoNA No responseNANANANA23028626
OV_2693AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNASpectrophotometer10 MOI50% cell viability after 96 hoursNoNoNA No responseNANANANA23028626
OV_2694AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneATCCHuman hepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNASpectrophotometer10 MOI80% cell viability after 24 hoursNoNoNA No responseNANANANA23028626
OV_2695AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneATCCHuman hepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNASpectrophotometer10 MOI60% cell viability after 48 hoursNoNoNA No responseNANANANA23028626
OV_2696AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneATCCHuman hepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNASpectrophotometer10 MOI40% cell viability after 72 hoursNoNoNA No responseNANANANA23028626
OV_2697AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneATCCHuman hepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNASpectrophotometer10 MOI40% cell viability after 96 hoursNoNoNA No responseNANANANA23028626
OV_2698AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNASpectrophotometer10 MOI85% cell viability after 24 hoursNoNoNA No responseNANANANA23028626
OV_2699AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNASpectrophotometer10 MOI80% cell viability after 48 hoursNoNoNA No responseNANANANA23028626
OV_2700AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNASpectrophotometer10 MOI70% cell viability after 72 hoursNoNoNA No responseNANANANA23028626
OV_2701AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNASpectrophotometer10 MOI40% cell viability after 96 hoursNoNoNA No responseNANANANA23028626
OV_2702AdenovirusAdCN205-IL12DNAAdenoviridaeNoneNoVirus in combination with CIKVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNASpectrophotometer10 MOI70% cell viability after 24 hoursNoNoNA No responseNANANANA23028626
OV_2703AdenovirusAdCN205-IL12DNAAdenoviridaeNoneNoVirus in combination with CIKVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNASpectrophotometer10 MOI40% cell viability after 48 hoursNoNoNA No responseNANANANA23028626
OV_2704AdenovirusAdCN205-IL12DNAAdenoviridaeNoneNoVirus in combination with CIKVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNASpectrophotometer10 MOI20% cell viability after 72 hoursNoNoNA No responseNANANANA23028626
OV_2705AdenovirusAdCN205-IL12DNAAdenoviridaeNoneNoVirus in combination with CIKVirus expressing IL-12 geneATCCHuman hepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNASpectrophotometer10 MOI90% cell viability after 24 hoursNoNoNA No responseNANANANA23028626
OV_2706AdenovirusAdCN205-IL12DNAAdenoviridaeNoneNoVirus in combination with CIKVirus expressing IL-12 geneATCCHuman hepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNASpectrophotometer10 MOI80% cell viability after 48 hoursNoNoNA No responseNANANANA23028626
OV_2707AdenovirusAdCN205-IL12DNAAdenoviridaeNoneNoVirus in combination with CIKVirus expressing IL-12 geneATCCHuman hepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNASpectrophotometer10 MOI10% cell viability after 72 hoursNoNoNA No responseNANANANA23028626
OV_2708AdenovirusAdCN205-IL12DNAAdenoviridaeNoneNoVirus strain in combination with CIK (1 × 10⁷ )Virus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-7NANANANANASCID mice xenograft for Huh7 (1.0E+6 cell)2.0E+8 pfuNA Reduction in tumor volume below 100mm after 40 days and increase in median survival time 40 daysIntratumoralNANANA23028626
OV_2709AdenovirusAdCN205-IL12DNAAdenoviridaeNoneNoVirus strain in combination with CIK (1 × 10⁷ )Virus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-7NANANANANASCID mice xenograft for Huh7 (1.0E+6 cell)2.0E+8 pfuNA Reduction in tumor volume below 100mm after 40 days and increase in median survival time 40 daysIntravenousNANANA23028626
OV_2710AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionYesNoNoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis5 MOI90% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2711AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionYesNoNoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis10 MOI85% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2712AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionYesNoNoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis20 MOI85% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2713AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionYesNoNoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis50 MOI80% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2714AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionYesNoNoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis100 MOI70% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2715AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionYesNoNoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis200 MOI60% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2716AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionNoVirus strain in combination with vincristine (0.1 nm)NoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis5 MOI90% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2717AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionNoVirus strain in combination with vincristine (1 nm)NoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis5 MOI70% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2718AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionNoVirus strain in combination with vincristine (5 nm)NoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis5 MOI60% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2719AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionNoVirus strain in combination with vincristine (10 nm)NoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis5 MOI50% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2720AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionNoVirus strain in combination with vincristine (50 nm)NoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis5 MOI40% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2721AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionNoVirus strain in combination with vincristine (50 nm)NoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis10 MOI90% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2722AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionNoVirus strain in combination with vincristine (50 nm)NoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis10 MOI70% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2723AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionNoVirus strain in combination with vincristine (50 nm)NoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis10 MOI50% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2724AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionNoVirus strain in combination with vincristine (50 nm)NoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis10 MOI50% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2725AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionNoVirus strain in combination with vincristine (50 nm)NoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis10 MOI40% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2726AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionNoVirus strain in combination with vincristine (50 nm)NoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis20 MOI90% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2727AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionNoVirus strain in combination with vincristine (50 nm)NoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis20 MOI70% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2728AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionNoVirus strain in combination with vincristine (50 nm)NoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis20 MOI50% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2729AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionNoVirus strain in combination with vincristine (50 nm)NoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis20 MOI50% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2730AdenovirusSG600DNAAdenoviridaeDeletion of E1A, E1B promoter and E1ACR2 regionNoVirus strain in combination with vincristine (50 nm)NoCentral south university,ChinaHuman retinoblastoma cell lineHXO-RB44NANAcell proliferation kit analysis20 MOI40% cell survivalNoNoNA No responseNAS-phase arrest and induction of apotosisDownregulation of Akt pathwayNA23109819
OV_2731AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI100% cell viability after 24 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2732AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI90% cell viability after 48 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2733AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI60% cell viability after 72 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2734AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI50% cell viability after 96 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2735AdenovirusAdCN205DNAAdenoviridaeNoneNoVirus strain in combination with miR-34-aVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI90% cell viability after 24 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2736AdenovirusAdCN205DNAAdenoviridaeNoneNoVirus strain in combination with miR-34-aVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI80% cell viability after 48 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2737AdenovirusAdCN205DNAAdenoviridaeNoneNoVirus strain in combination with miR-34-aVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI50% cell viability after 72 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2738AdenovirusAdCN205DNAAdenoviridaeNoneNoVirus strain in combination with miR-34-aVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI30% cell viability after 96 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2739AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNAMTT assay5 MOI100% cell viability after 24 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2740AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNAMTT assay5 MOI90% cell viability after 48 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2741AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNAMTT assay5 MOI82% cell viability after 72 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2742AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNAMTT assay5 MOI78% cell viability after 96 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2743AdenovirusAdCN205DNAAdenoviridaeNoneNoVirus strain in combination with miR-34-aVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNAMTT assay5 MOI90% cell viability after 24 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2744AdenovirusAdCN205DNAAdenoviridaeNoneNoVirus strain in combination with miR-34-aVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNAMTT assay5 MOI80% cell viability after 48 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2745AdenovirusAdCN205DNAAdenoviridaeNoneNoVirus strain in combination with miR-34-aVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNAMTT assay5 MOI60% cell viability after 72 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2746AdenovirusAdCN205DNAAdenoviridaeNoneNoVirus strain in combination with miR-34-aVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNAMTT assay5 MOI40% cell viability after 96 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2747AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNAMTT assay5 MOI90% cell viability after 24 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2748AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNAMTT assay5 MOI80% cell viability after 48 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2749AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNAMTT assay5 MOI60% cell viability after 72 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2750AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNAMTT assay5 MOI40% cell viability after 96 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2751AdenovirusAdCN205DNAAdenoviridaeNoneNoVirus strain in combination with miR-34-aVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNAMTT assay5 MOI90% cell viability after 24 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2752AdenovirusAdCN205DNAAdenoviridaeNoneNoVirus strain in combination with miR-34-aVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNAMTT assay5 MOI50% cell viability after 48 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172